Central Retinal Vein Occlusion Associated with Platelet Activation

Overview

Journal Ther Adv Ophthalmol

Specialty Ophthalmology

Date 2019 Aug 7

PMID 31384723

Citations 6

Authors

Mehmet Citirik

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this article is to determine and compare the platelet activation by three main platelet activation parameters: mean platelet volume, platelet distribution width, and plateletcrit in patients with central retinal vein occlusion and control subjects.

Methods: This study included 30 patients with nonischemic central retinal vein occlusion and 30 control subjects. The levels of mean platelet volume, platelet distribution width, and plateletcrit were measured in all groups.

Results: The mean serum level of mean platelet volume was 10.01 ± 0.89 fl in central retinal vein occlusion group and 8.74 ± 1.45 fl in control group. The mean serum level of platelet distribution width was 14.31 ± 1.49% and 11.65 ± 1.81% in central retinal vein occlusion group and control group, respectively. Mean serum plateletcrit value was 0.27 ± 0.07% in central retinal vein occlusion group and 0.23 ± 0.07% in control group. Mean platelet volume, platelet distribution width, and plateletcrit levels were significantly higher in central retinal vein occlusion patients than controls ( < 0.05).

Conclusion: Subclinical platelet activation reflected by mean platelet volume, platelet distribution width, and plateletcrit may have an impact on the genesis of vessel occlusion in central retinal vein occlusion. The results may be important for the clinical management of patients with central retinal vein occlusion.

Citing Articles

Molecular and Cellular Mechanisms Involved in the Pathophysiology of Retinal Vascular Disease-Interplay Between Inflammation and Oxidative Stress.

Srejovic J, Muric M, Jakovljevic V, Srejovic I, Sreckovic S, Petrovic N Int J Mol Sci. 2024; 25(21).

PMID: 39519401 PMC: 11546760. DOI: 10.3390/ijms252111850.

Platelet-Derived Procoagulant Microvesicles Are Elevated in Patients with Retinal Vein Occlusion (RVO).

Marcinkowska A, Wolska N, Luzak B, Cisiecki S, Marcinkowski K, Rozalski M J Clin Med. 2022; 11(17).

PMID: 36079028 PMC: 9457368. DOI: 10.3390/jcm11175099.

Complete Blood Count-Derived Inflammation Indices and Retinal Vein Occlusion: A Case-Control Study.

Kazantzis D, Machairoudia G, Kroupis C, Theodossiadis G, Theodossiadis P, Chatziralli I Ophthalmol Ther. 2022; 11(3):1241-1249.

PMID: 35503164 PMC: 9114275. DOI: 10.1007/s40123-022-00511-0.

The effect of select systemic medications on outcomes in diabetics with central retinal vein occlusion.

Simmons K, Singh P, Borkar D, Birnbaum F, Thomas A, Fekrat S Ther Adv Ophthalmol. 2022; 14:25158414211063076.

PMID: 35083418 PMC: 8785328. DOI: 10.1177/25158414211063076.

Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study.

Paciullo F, Menduno P, Tucci D, Caricato A, Cagini C, Gresele P Intern Emerg Med. 2022; 17(4):1065-1071.

PMID: 35028874 DOI: 10.1007/s11739-021-02905-7.

References

Kadayifcilar S, Ozatli D, Ozcebe O, Sener E . Is activated factor VII associated with retinal vein occlusion?. Br J Ophthalmol. 2001; 85(10):1174-8. PMC: 1723720. DOI: 10.1136/bjo.85.10.1174. View

Hayreh S, Zimmerman M, Podhajsky P . Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002; 240(3):180-96. DOI: 10.1007/s00417-001-0421-3. View

Amin M, Amin A, Kulkarni H . Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease. Ann Hematol. 2004; 83(6):331-5. DOI: 10.1007/s00277-003-0833-8. View

Huczek Z, Kochman J, Filipiak K, Horszczaruk G, Grabowski M, Piatkowski R . Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2005; 46(2):284-90. DOI: 10.1016/j.jacc.2005.03.065. View

Meyer C, Schmidt J, Rodrigues E, Mennel S . Risk of retinal vein occlusions in patients treated with rofecoxib (vioxx). Ophthalmologica. 2005; 219(4):243-7. DOI: 10.1159/000085735. View

Coban E, Adanir H, Bilgin D . The association of mean platelet volume levels with hypertensive retinopathy. Platelets. 2007; 19(2):115-8. DOI: 10.1080/09537100701230451. View

Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I . Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14(1):28-32. PMC: 2843567. View

Muxel S, Fasola F, Radmacher M, Jabs A, Munzel T, Gori T . Endothelial functions: Translating theory into clinical application. Clin Hemorheol Microcirc. 2010; 45(2-4):109-15. DOI: 10.3233/CH-2010-1288. View

Laouri M, Chen E, Looman M, Gallagher M . The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond). 2011; 25(8):981-8. PMC: 3178209. DOI: 10.1038/eye.2011.92. View

10.

Hayreh S, Podhajsky P, Zimmerman M . Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants. Ophthalmology. 2011; 118(8):1603-11. PMC: 3150626. DOI: 10.1016/j.ophtha.2011.04.036. View

11.

Kodiatte T, Manikyam U, Rao S, Jagadish T, Reddy M, Malligere Lingaiah H . Mean platelet volume in Type 2 diabetes mellitus. J Lab Physicians. 2012; 4(1):5-9. PMC: 3425267. DOI: 10.4103/0974-2727.98662. View

12.

Sahin F, Yazar E, Yildiz P . Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis. Multidiscip Respir Med. 2012; 7(1):38. PMC: 3529701. DOI: 10.1186/2049-6958-7-38. View

13.

Akpinar I, Sayin M, Gursoy Y, Karabag T, Kucuk E, Buyukuysal M . Plateletcrit. A platelet marker associated with saphenous vein graft disease. Herz. 2013; 39(1):142-8. DOI: 10.1007/s00059-013-3798-y. View

14.

Sahin A, Sahin M, Yuksel H, Turkcu F, Cinar Y, Cingu A . The mean platelet volume in patients with retinal vein occlusion. J Ophthalmol. 2013; 2013:236371. PMC: 3679690. DOI: 10.1155/2013/236371. View

15.

Citirik M, Beyazyildiz E, Simsek M, Beyazyildiz O, Haznedaroglu I . MPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy. Eye (Lond). 2014; 29(3):376-9. PMC: 4366465. DOI: 10.1038/eye.2014.298. View

16.

Sahin M, Sahin A, Yuksel H, Turkcu F, Yildirim A . Mean platelet volume in patients with retinal artery occlusion. Arq Bras Oftalmol. 2016; 79(1):12-4. DOI: 10.5935/0004-2749.20160005. View

17.

Yilmaz T, Yilmaz A . Altered platelet morphological parameters in patients with retinal vein occlusion. Eur Rev Med Pharmacol Sci. 2016; 20(10):1934-9. View

18.

Kuhli-Hattenbach C, Hellstern P, Kohnen T, Hattenbach L . Platelet activation by ADP is increased in selected patients with anterior ischemic optic neuropathy or retinal vein occlusion. Platelets. 2017; 28(7):720-723. DOI: 10.1080/09537104.2016.1276548. View

19.

Beyazyildiz E, Citirik M, Simsek M, Beyazyildiz O, Haznedaroglu I . Branch retinal vein occlusion associated with platelet activation. Turk J Med Sci. 2019; 49(1):283-287. PMC: 7350854. DOI: 10.3906/sag-1807-223. View

20.

Bawankar P, Samant P, Lahane T, Parekh R, Lahane S . Mean platelet volume and central retinal vein occlusion in hypertensive patients. Can J Ophthalmol. 2019; 54(2):275-279. DOI: 10.1016/j.jcjo.2018.04.014. View